$599

Merck Acquires Silence; Sanofi Insulin Manufacturing Expansion; Lilly Ph3 EloraTZP Pivotal Studies; Cytokinetics Myqorzo Health Canada Approval

A series of cardiometabolic-related news items has been observed from Merck KGaA, Sanofi, Lilly, and Cytokinetics. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here